Skip to main content
BTC / USDTCRYPTO107,400+2.19%ETH / USDTCRYPTO3,840+2.13%SOL / USDTCRYPTO182.40−1.99%BNB / USDTCRYPTO652.30+0.66%XRP / USDTCRYPTO2.2150+1.61%DOGE / USDTCRYPTO0.3850−1.79%TON / USDTCRYPTO5.240+2.34%AVAX / USDTCRYPTO42.60−2.07%LINK / USDTCRYPTO22.40+2.28%ADA / USDTCRYPTO1.0520−1.68%TRX / USDTCRYPTO0.3300+0.92%DOT / USDTCRYPTO8.420+2.93%BTC / USDTCRYPTO107,400+2.19%ETH / USDTCRYPTO3,840+2.13%SOL / USDTCRYPTO182.40−1.99%BNB / USDTCRYPTO652.30+0.66%XRP / USDTCRYPTO2.2150+1.61%DOGE / USDTCRYPTO0.3850−1.79%TON / USDTCRYPTO5.240+2.34%AVAX / USDTCRYPTO42.60−2.07%LINK / USDTCRYPTO22.40+2.28%ADA / USDTCRYPTO1.0520−1.68%TRX / USDTCRYPTO0.3300+0.92%DOT / USDTCRYPTO8.420+2.93%
AboutPameran TradersPenghargaan TradersGame Perdagangan
/
Harga
Mulai→

NEO shaping up after jobs miss

June payrolls missed by a mile, and NeoGenomics is catching a bid. Worth a look here.

Hiro Tanaka·Jul 2, 2026·1 min read

June nonfarm payrolls came in at 57K — way under the 100K+ whisper. That takes another rate hike off the table for now, and growth names with measurable catalysts are getting repriced.

NeoGenomics (NEO) is one of them. The pathology platform has been consolidating, and the macro relief could give it the next leg. I'm watching for volume confirmation before adding.

Comments5

  • Priya Nair
    The jobs miss creates a liquidity tailwind for growth names like NEO. Worth noting their oncology testing pipeline is strong, so the bid could stick if they execute well. 📈
  • Tom Fielding
    Jobs miss doesn't change the fact NEO's been bleeding revenue growth for a year. Catching a bid on macro noise isn't a thesis.
  • Sofia Reyes
    Interesting how a macro miss can give micro-cap biotech a lift—almost like money rotating out of rate-sensitive plays. Do you see NEO's recent volume as enough to confirm a real breakout, or is this just a knee-jerk reaction? 🤔
  • Lena Brandt
    The payroll miss is a macro catalyst, but NEO’s move suggests the risk is in chasing momentum post-news. The reward window narrows without a pullback to a better entry.
  • Marcus Vega
    Misses are priced in fast. NEO's bid says the market sees this as noise, not signal. 🚀🔥